Option Care Health Inc. logo

Option Care Health Inc. (MM6A)

Market Open
12 Dec, 20:00
XFRA XFRA
27. 60
0
0%
- Market Cap
21 P/E Ratio
0% Div Yield
99 Volume
1.13 Eps
27.6
Previous Close
Day Range
27.6 27.6
Year Range
21.6 32.4
Want to track MM6A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 72 days

Summary

MM6A trading today higher at €27.6, an increase of 0% from yesterday's close, completing a monthly increase of 4.55% or €1.2. Over the past 12 months, MM6A stock gained 23.21%.
MM6A is not paying dividends to its shareholders.
The last earnings report, released on Oct 30, 2025, missed the consensus estimates by -0.43%. On average, the company has fell short of earnings expectations by -0.14%, based on the last three reports. The next scheduled earnings report is due on Feb 25, 2026.
Option Care Health Inc. has completed 1 stock splits, with the recent split occurring on Feb 03, 2020.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

MM6A Chart

Option Care Health, Inc. (OPCH) Presents at Bank of America Leveraged Finance Conference Transcript

Option Care Health, Inc. (OPCH) Presents at Bank of America Leveraged Finance Conference Transcript

Option Care Health, Inc. (OPCH) Presents at Bank of America Leveraged Finance Conference Transcript

Seekingalpha | 1 week ago
Option Care Health, Inc. (OPCH) Presents at UBS Global Healthcare Conference 2025 Transcript

Option Care Health, Inc. (OPCH) Presents at UBS Global Healthcare Conference 2025 Transcript

Option Care Health, Inc. ( OPCH ) UBS Global Healthcare Conference 2025 November 11, 2025 3:30 PM EST Company Participants Meenal Sethna - Executive VP & CFO Nicole Maggio Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Presentation Albert Rice UBS Investment Bank, Research Division Okay. We're ready to get going.

Seekingalpha | 1 month ago
Option Care Health, Inc. (OPCH) Q3 2025 Earnings Call Transcript

Option Care Health, Inc. (OPCH) Q3 2025 Earnings Call Transcript

Option Care Health, Inc. ( OPCH ) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Company Participants Nicole Maggio - Senior VP, Controller & Principal Accounting Officer John Rademacher - CEO, President & Director Meenal Sethna - Executive VP & CFO Conference Call Participants Pito Chickering - Deutsche Bank AG, Research Division Joanna Gajuk - BofA Securities, Research Division David MacDonald - Truist Securities, Inc., Research Division Matthew Larew - William Blair & Company L.L.C., Research Division Lucas Romanski - TD Cowen, Research Division Constantine Davides - Citizens JMP Securities, LLC, Research Division Brian Tanquilut - Jefferies LLC, Research Division Michael Petusky - Barrington Research Associates, Inc., Research Division Presentation Operator Good day, and thank you for standing by.

Seekingalpha | 1 month ago

Option Care Health Inc. (MM6A) FAQ

What is the stock price today?

The current price is €27.60.

On which exchange is it traded?

Option Care Health Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is MM6A.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.46.

When is the next earnings date?

The next earnings report will release on Feb 25, 2026.

Has Option Care Health Inc. ever had a stock split?

Option Care Health Inc. had 1 splits and the recent split was on Feb 03, 2020.

Option Care Health Inc. Profile

Health Care Providers & Services Industry
Healthcare Sector
John C. Rademacher CEO
XFRA Exchange
US68404L2016 ISIN
US Country
8,000 Employees
- Last Dividend
3 Feb 2020 Last Split
15 Aug 1996 IPO Date

Overview

Option Care Health, Inc., based in Bannockburn, Illinois, stands as a prominent provider of home and alternate site infusion services across the United States. By delivering a broad spectrum of infusion and nursing services, the company plays a critical role in the healthcare continuum, particularly for patients requiring complex treatments outside of hospital settings. Catering to a wide range of acute and chronic conditions, Option Care Health, Inc. emphasizes a patient-centered approach, utilizing a vast network of professionals and resources to ensure high-quality care. The company's outreach is facilitated through strategic marketing to patient referrals, including physicians, hospital discharge planners, health maintenance organizations, and preferred provider organizations, establishing it as a preferred choice for infusion services in the healthcare landscape.

Products and Services

  • Anti-infective Therapies: Offering essential treatments to combat various infections, pivotal for patients who require intravenous medications at home or in settings other than hospitals.
  • Heart Failure Therapies: Providing home infusion services tailored for heart failure patients, aiming at improving quality of life and reducing hospital readmissions.
  • Nutrition Support Services: Delivering comprehensive home parenteral (IV) and enteral (feeding tube) nutrition support for patients dealing with the aftermath of strokes, cancer, and gastrointestinal diseases, among other conditions.
  • Immunoglobulin Infusion Therapies: Specializing in treatments for immune deficiencies through immunoglobulin therapies, assisting patients with compromised immune systems to fight infections and diseases.
  • Treatments for Chronic Inflammatory Disorders: Offering infusion therapies for chronic conditions like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, aiming to manage and alleviate the symptoms associated with chronic inflammatory disorders.
  • Neurological Disorder Management: Facilitating treatments that manage the progression of numerous neurological disorders, including multiple sclerosis and duchenne muscular dystrophy, enhancing patient outcomes through specialized infusion therapies.
  • Infusion Therapies for Bleeding Disorders: Providing critical care for patients with hemophilia and von Willebrand disease through specialized infusion therapies, aimed at managing bleeding episodes and improving quality of life.
  • High-risk Pregnancy Therapies: Offering dedicated therapies for women experiencing high-risk pregnancies, helping to manage conditions that could threaten the health of the mother or baby.
  • Comprehensive Infusion Therapies: Addressing a wide array of conditions with infusion therapies, including pain management, chemotherapy, and respiratory medications, supplemented by professional nursing services.

Contact Information

Address: 3000 Lakeside Drive
Phone: 312 940 2443